Team:Bielefeld-CeBiTec/Notebook/Journal/Biosafety/Jun

From 2014.igem.org

(Difference between revisions)
Line 30: Line 30:
<table width="100%" style="background-color:transparent">  
<table width="100%" style="background-color:transparent">  
<tr>
<tr>
-
<td width="100px"><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Journal/Biosafety/May"><img src="https://static.igem.org/mediawiki/2014/b/b9/Bielefeld-CeBiTec_2014-08-14_Arrrow-left.png" width="50px"> </a></td>
+
<td width="100px"></td>
<td style="padding:30px; width:400px"><h1> June </h1></td>
<td style="padding:30px; width:400px"><h1> June </h1></td>
<td width="100px" align="right"><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Journal/Biosafety/Jul"><img src="https://static.igem.org/mediawiki/2014/9/9b/Bielefeld-CeBiTec_2014-08-14_Arrow-right.png" width="50px"> </a>      </td>
<td width="100px" align="right"><a href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Journal/Biosafety/Jul"><img src="https://static.igem.org/mediawiki/2014/9/9b/Bielefeld-CeBiTec_2014-08-14_Arrow-right.png" width="50px"> </a>      </td>

Revision as of 16:47, 31 August 2014


June

  • Design of the Primer for the deletion of the whole coding sequence of the constitutive alanine racemase (alr) and the catabolic alanine racemase (dadX) from E. coli using the Genebridge Red/ET-System.
  • Design of the Primer for the integration of the konstitutive alanine racemase alr into the pSB1C3-Backbone.
  • Successful amplifikation of the oligonucleotide containing the flanking sites for the deletion of alr and purification using the gel extraction clean-up kit from Promega.
  • Transformation of the oligonucleotide containing the flanking sites for the deletion of alr. The successful replacement of the constitutive alanine racemase was verified via kanamycin selection and Colony PCR (alr_Ec_control1, alr_Ec_control2)
    • Annealing temperature: 55 °C
    • Bands as expected (3004 bp)
  • Resulting in the genotype KRX kan:alr, DH5aplha kan:alr repsectivly.